Millstone Evans Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5K Hold
82
﹤0.01% 726
2026
Q1
$3.95K Hold
82
﹤0.01% 683
2025
Q4
$3.97K Hold
82
﹤0.01% 674
2025
Q3
$3.87K Hold
82
﹤0.01% 662
2025
Q2
$3.96K Hold
82
﹤0.01% 610
2025
Q1
$4.55K Hold
82
﹤0.01% 618
2024
Q4
$3.96K Buy
+82
New +$4.17K ﹤0.01% 595

Other funds holding SNY

Millstone Evans Group's SNY Position: Q2 2026 in Review

Millstone Evans Group held its Sanofi (SNY) position steady in Q2 2026 at 82 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Millstone Evans Group first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.55K in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Millstone Evans Group held 82 shares of Sanofi worth $3.5K as of Q2 2026.
  • Millstone Evans Group left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Millstone Evans Group's portfolio in Q2 2026, its #726 holding.
  • Millstone Evans Group first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's Sanofi position peaked at $4.55K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.